Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dexmedetomidine Versus Propofol for Continuous Sedation in the Intensive Care Unit (ICU) (Prodex)

This study has been completed.
Sponsor:
Information provided by:
Orion Corporation, Orion Pharma
ClinicalTrials.gov Identifier:
NCT00479661
First received: May 25, 2007
Last updated: August 12, 2010
Last verified: August 2010